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Abstract
Apurinic/apyrimidinic endonuclease (APE1) is an essential base excision repair protein that also
functions as a reduction/oxidation (redox) factor in mammals. Through a thiol-based mechanism,
APE1 reduces a number of important transcription factors including AP-1, p53, NF-κB, and
HIF-1α. What is known about the mechanism to date is that the buried Cys residues 65 and 93 are
critical for APE1’s redox activity. To further detail the redox mechanism, we developed a
chemical footprinting/mass spectrometric assay using N-ethylmaleimide (NEM), an irreversible
Cys modifier, to characterize the interaction of the redox inhibitor, E3330, with APE1. When
incubated with E3330, two NEM-modified products were observed, one with 2 and a second with
7 added NEMs; this latter product corresponds to a fully modified APE1. In a similar control
reaction without E3330, only the +2NEM product was observed in which the two solvent
accessible Cys residues, C99 and C138, were modified by NEM. Through hydrogen-deuterium
amide exchange with analysis by mass spectrometry, we found that the +7NEM modified species
incorporates approximately 40 more deuterium atoms than the native protein, which exchanges
nearly identically as the +2NEM product, suggesting that APE1 can be trapped in a partially
unfolded state. E3330 was also found to increase disulfide bond formation involving redox critical
Cys residues in APE1 as assessed by LC-MS/MS, suggesting a basis for its inhibitory effects on
APE1’s redox activity. Collectively, our results suggest that APE1 adopts a partially unfolded
state, which we propose is the redox active form of the enzyme.
Regulation of cellular processes by reduction-oxidation (redox) is critical for cell
survival(1). Oxidation of proteins can result in loss of function owing to the formation of
disulfide bonds, some of which are reduced by general redox factors such as thioredoxin and
glutaredoxin (2,3). Both thioredoxin and glutaredoxin include a C-X-X-C motif in which
one Cys serves as the nucleophile forming a mixed disulfide bond with the substrate protein,
and the second Cys resolves the mixed disulfide bond forming a disulfide bond in the redox
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factor thereby leaving the substrate protein in a reduced state (4). Thioredoxin is itself
reduced by thioredoxin reductase whereas glutaredoxin is reduced by glutathione, which is
then reduced by glutathione reductase (2,3,5).
A number of transcription factors are subject to redox regulation, the first known example
being AP-1 (c-Jun/c-Fos) (6,7). The nuclear factor responsible for reducing c-Jun/c-Fos was
identified as Ref-1, also known as apurinic/apyrmidinic endonuclease (APE1), an essential
base excision repair enzyme (8). As redox regulation of c-Jun was known to involve a Cys
residue within its DNA-binding domain, reduction of c-Jun was proposed to involve a thiol-
exchange mechanism. Of the seven Cys residues in APE1, substitution of a single Cys
residue, namely Cys 65, with Ala results in loss of redox activity (9). The critical role of Cys
65 was further confirmed through mutational analysis of the redox inactive zebrafish APE
(zAPE), which has a Thr residue (Thr 58) in the position equivalent to Cys 65. The Thr 58 to
Cys substituted zAPE gains redox function through this single amino acid substitution (10).
A second Cys residue implicated in the redox activity through mutational analysis is Cys 93
(9,10). Not only does APE1 lack the C-X-X-C motif found in thioredoxin and glutaredoxin,
but also the critical redox residues Cys 65 and Cys 93 are buried residues. Further, none of
the Cys residues are positioned appropriately to form disulfide bonds as is revealed by the
crystal structures reported for APE1(3). Thus, the mechanism by which APE1 acts as a
redox factor poses an interesting problem to solve.
Toward our goal of elucidating the mechanism by which APE1 reduces transcription factors
including AP-1, NF-κB, HIF-1α, p53, and others (3,8,11-13), we took advantage of the
redox inhibitor, (E)-3-(2-(5,6-dimethoxy-3-methyl-1,4-benzoquinonyl))-2-nonyl propenoic
acid (E3330), which was reported to interact directly with APE1 (14) and to inhibit its redox
activity but not its DNA repair endonuclease activity (15). Here, we report an investigation
of the nature of the interaction of APE1 and E3330 by using MS analysis of the amide
hydrogen/deuterium exchange (HDX) (16-19) and of N-ethylmaleimide (NEM) labeling
(20-22). Our results reveal a novel mode of interaction between E3330 and APE1 and
provide new insights on the redox mechanism of APE1.
Experimental Procedures
Preparation of APE1 enzymes
Δ40APE1, an N-terminal truncation of APE1 including residues 40-318 was subcloned into
pET28 using BamH1 and XhoI restriction sites with an N-terminal hexa-His affinity tag.
The Δ40APE1 vector was transformed into Rosetta (DE3) E. coli (Novagen, Inc.), and
cultures were grown at 37 °C in 20 μg/mL kanamycin and 34 μg/mL choramphenicol until
OD at 600 nm reached 0.6 and then induced by using 1mM IPTG for 3 hours at 37 °C. The
protein was purified as previously described by using Ni-NTA affinity purification followed
by S-sepharose ion exchange chromatography (10). The hexa-His tag was then removed by
digestion with thrombin, and the protein purified by using S-sepharose ion exchange
chromatography. Site-directed mutagenesis using the Stratagene Quikchange kit was used to
introduce C65A, C99A, C138A, and C99A/C138A substitutions in Δ40APE1 and
confirmed by DNA sequencing analysis. Substituted Δ40APE1 proteins were expressed and
purified as described for Δ40APE1.
Full-length APE1was subcloned into an N-terminal hexa-His- SUMO-fusion (Invitrogen)
vector. The fusion construct was transformed into Rosetta (DE3) E. coli (Novagen, Inc.),
grown in 3 L of LB media with 20 μg/mL kanamycin and 34 μg/mL chloramphenicol until
the OD at 600 nm reached 0.6, and then induced overnight with 1 mM IPTG at 15 °C. The
cultures were harvested by centrifugation at 4000 x g for 30 min, and the pellets were stored
at −80 °C. The cell pellets were each resuspended in 20 mL of 50 mM sodium phosphate
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buffer pH 7.8, 0.3 M NaCl, 10 mM imidazole, and then lysed by using a French press
(SLM-AMINCO, Spectronic Instruments, Rochester, USA) at 1000 psi. The suspension was
centrifuged at 35,000 rpm for 35 min, and the supernatant was then loaded on a Ni-NTA
column at 4 °C. The column was washed with 20 column volumes of 50 mM sodium
phosphate buffer pH 7.8, 0.3 M NaCl, 20 mM imidazole protein and then incubated
overnight with the SUMO-specific protease Ulp1, added at a molar ratio of ~1:1000
(Ulp1:APE1). Full-length APE1 was then eluted from the column in the same buffer and
further purified using an S-Sepharose column run in 50 mM MES pH 6.5, 1 mM DTT, and a
linear NaCl gradient (0.05-1 M). The peak fractions were then combined, concentrated, and
subjected to gel filtration chromatographic separation using a Superdex 75 (Amersham
Pharmacia) in 50 mM Tris pH 8.0, 0.1 M NaCl. Fractions containing full-length APE1 were
then concentrated using Amicon ultra centrifugal concentrators and stored at −80 °C.
NanoESI (nESI) MS
Δ40APE1 was incubated in 1 M ammonium acetate (pH 7.5) with or without E3330 at room
temperature (RT) for 4 h. E3330 was synthesized by the Vahlteich Medicinal Chemistry
Core, University of Michigan, Dept. of Medicinal Chemistry, Ann Arbor, MI. The
compound was dissolved in DMSO and stored at −20° C as a 100 mM stock solution. The
stock solution was diluted prior to addition to protein samples resulting in a final DMSO
concentration of 5%. Control samples also included 5% DMSO. Protein samples were
analyzed by nESI-MS in the positive-ion mode on a Bruker MaXis UHR-TOF (ultra-high
resolution time-of-flight) (Bruker Daltonics Inc., Billerica, MA) at a flow rate of 25 nL/min.
nESI conditions were adjusted to observe the tetrameric form of lactate dehydrogenase in
the mass spectrum as a control for the formation of weak complexes. The capillary voltage
was set at −(1000-1200 V). Dry gas and temperature were at 5.0 L/min and 50 °C,
respectively. The instrument was externally calibrated by using “Tuning Mix” (Agilent
Technologies, Santa Clara, CA). The spray tips were made in-house by pulling a 150 μm i.d.
× 365 μm o.d. fused silica capillary with a P-2000 Laser Puller (Sutter Instrument Co.,
Novato, CA). A four-step program was used with the parameter setup as follows with all
other values set to zero: Heat = 290, velocity = 40, delay = 200; Heat = 280, velocity = 30,
delay = 200; Heat = 270, velocity = 25, delay = 200; Heat = 260, velocity = 20, delay = 200.
Tips were cut accordingly to allow a good spray under the experimental conditions. For each
sample, a new tip was used to avoid cross contamination.
NEM Chemical Footprinting and ESI-MS
For NEM labeling, 10-20 μL of Δ40APE1/NEM (Δ40APE1:NEM = 1:5, mol/mol) and
Δ40APE1/NEM/E3330 (Δ40APE1:NEM:E3330 = 1:5:5, mol/mol/mol) Δ40APE1 samples
were incubated in 10 mM HEPES buffer (pH 7.5) at room temperature; the protein
concentration was 100 μm. Both control and E3330 treated samples contained 5% DMSO.
At a certain time, a 1 μL aliquot was removed and quenched with 1 μL of 20 mM DTT.
Samples were then diluted with water to 1 μm followed by 5 μL injection for MS analysis.
Mass spectra were collected on the Bruker MaXis UHR-TOF or Waters Micromass Q-TOF
instrument (Waters-Micromass, Manchester, UK). The parameters for MaXis mass
spectrometer were as follows: capillary voltage was −3600 V, nebulizer pressure was 0.4
bar, drying gas was 1.0 L/min, and drying temperature was 180°C. The instrument was
calibrated using Tuning Mix (Agilent Technologies; Santa Clara, CA) as the external mass
calibrant. The parameters for the Waters Q-TOF instrument were as follows: Z-Spray source
was operated at 2.8 kV, the cone voltage was 150 V, and RF lens was 50. The source
temperature and desolvation temperatures were 80 ° and 180 °C, respectively. The collision
energy was 10 eV, and the MCP detector was 2,200 V. Protein samples were loaded on an
Opti-Guard C18 column (10 mm × 1 mm i.d., Cobert Associates, St. Louis, MO) for
Su et al. Page 3
Biochemistry. Author manuscript; available in PMC 2012 June 8.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
desalting and then eluted to the mass spectrometer by using 50% (v/v) acetonitrile with 0.1%
formic acid (FA) at 10 μL/min. Spectral deconvolution was performed using MaxEnt.
Data Processing of NEM-Labeling
A number of the equation parameters were extracted from the kinetic data by nonlinear least
squares fitting of theoretical signals, computed from the parameter dependent system state
trajectories, to experiment data. The system state was a vector that has the solution chemical
species concentrations as the vector coordinates. In each trial of the search, the postulated
parameters together with the system state of concentrations permitted the calculation of the
time rate of change of the state by computing the fluxes into and out of each species as
described by the system equations. This process implemented a vector first-order ordinary
differential equation, which was solved by numerical integration for the time interval of
reaction initiation to the longest reaction time to give the state time trajectory in each fitting
trial. For comparison with the experiment data, the theoretical signal for each APE1 species
was computed as a fraction of all APE1 species concentrations that were first weighted by a
relative sensitivity factor that varied linearly with slope gN with the number of NEMs
attached starting with one for Δ40APE1 by itself. The calculations were carried out in the
computer application Mathcad 14.0 M010 (Parametric Technology Corporation, Needham,
MA). The numerical integration of the differential equation was carried out by the adaptive
fourth-order Runge-Kutta function “Rkadapt”.
HDX and Electrospray Ionization Mass Spectrometry (ESI-MS) of the NEM adducts of
Δ40APE1
A 30 μL solution of Δ40APE1/E3330/NEM was incubated with 10 mM HEPES (pH 7.5)
for 22 h at RT ([protein] = 100 μm; [E3330] = [NEM] = 500 μm). To quench the NEM
labeling reaction, 0.5 μL of 1 M DTT was added to the above solution. An aliquot of the 2.8
μL DTT quenched solution was diluted to a final volume of 40 μL of 93% D2O medium
with 10 mM HEPES (pH 7.5) and 150 mM KCl and incubated for various times to obtain
the HDX kinetics at 25 °C. The HDX reaction was quenched by adding 1 μL of 1 M cold
HCl. ESI-MS and data processing were the same as described above.
LC-MS/MS Experiments
Analysis of disulfide bonds—A 200 μL solution of Δ40APE1 (10 μm) and E3330 (50
μm) was incubated in 10 mM HEPES (pH = 7.5) at 37 °C for 1 h. Typically, a 100-fold
molar excess of NEM was added to the sample immediately after the incubation to prevent
disulfide-bond scrambling during the course of digestion. The Δ40APE1sample was diluted
with water to a final concentration of 1 μm and then digested using a protein:trypsin ratio of
50:1 at 37 °C for 4 h. Native digestion conditions were similar to those successfully used for
other problems involving purified protein samples(23,24). The solution was then analyzed
by LC-MS/MS whereby 5 μL of digestion solution was consumed for each experiment.
Measurements were done for three independent experimental replicates. Reversed-phase
capillary LC separations were performed with an Eksigent NanoLC-1D pump (Eksigent
Technologies, Inc. Livermore, CA). The reversed-phase capillary column (0.075 mm × 150
mm) was packed in-house by using a PicoFrit™ tip (New Objective, Inc., Woburn, MA)
with C18 particles (Magic, 5 μm, 120 Å, Michrom Bioresources, Inc., Auburn, CA). The
mobile phase consisted of water, with 0.1% formic acid (solvent A) and acetonitrile with
0.1% formic acid (solvent B). Immediately after sample loading, the mobile phase was held
at 98% A for 12 min. A linear gradient was used with 2% to 60% solvent B over 60 min,
then to 80% solvent B over 10 min at 260 nL/min followed by a 12 min re-equilibration step
by 100% solvent A. The flow was directed by PicoView Nanospray Source (PV550, New
Objective, Inc., Woburn, MA) to the LTQ Orbitrap (Thermo Fisher Scientific, Inc., San
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Jose, CA). The spray voltage was 1.8-2.2 kV, and the capillary voltage was 27 V. The LTQ
Orbitrap was operated in standard data-dependent MS/MS acquisition mode controlled by its
Xcalibur 2.0.7 software, in which a full mass spectral scan was followed by six product-ion
(MS/MS) scans. The mass spectra of the peptides were acquired at high mass resolving
power (60,000 for ions of m/z 400) with the FT analyzer over the range of m/z 350-2000.
The six most abundant precursor ions were dynamically selected in the order of highest to
lowest signal intensity (minimal intensity of 1000 counts) and subjected to collision-induced
dissociation (CID). Precursor activation was performed with an isolation width of 2 Da and
activation time 30 ms. The normalized collision energy was 35% of the maximum available.
The automatic gain control target value was regulated at 1 × 106 for the FT analyzer and 3 ×
104 for the ion trap with a maximum injection time of 1000 ms for the FT analyzer and 200
ms for the ion trap. The instrument was externally calibrated by using a standard calibration
mixture of caffeine, the peptide MRFA, and Ultramark 1621 (Thermo Fisher Scientific, Inc.,
San Jose, CA). To identify covalent modifications LC-MS/MS data were searched with
Mascot 2.2 (Matrix Science, London, UK) against the NCBI database or MassMatix, an in-
house search engine developed by Xu et al.(25-27). Parameters used in Mascot were:
enzyme, trypsin; maximum missed cleavage, 3; peptide mass tolerance, 10 ppm with one C
13 peak; peptide charge, +1 to +3; product mass tolerance, 0.6 Da; instrument type, default
(searching for all types of b and y ions). To locate disulfide bonds, LC-MS/MS data were
searched with MassMatrix with the following parameter settings: enzyme, trypsin;
maximum missed cleavage, 3; variable number of modifications by NEM on cysteines;
precursor ion tolerance, 10 ppm; product ion tolerance, 0.8 Da; max # PTM per peptide, 2;
minimum peptide length, 4 amino acids; maximum peptide length, 40 amino acids; min pp
score, 5.0; min pptag score 1.3; max # match per peptide, 3; max # combination per match,
3; fragmentation method, CID; C13 isotope ions, 1; crosslink, disulfide; crosslink mode,
exploratory; crosslink sites cleavability, not applicatble; max # crosslinks per peptide, 2.
Analysis of E3330 or NEM adducts—Samples of Δ40APE1 (100 μM) and E3330 (500
μM) were incubated at room temperature for varying lengths of time and analyzed for
formation of covalent adducts with E3330 by LC-MS/MS as described above. NEM-
modified samples, generated in the chemical footprinting experiment described above, were
analyzed using the same protocol as described above for the disulfide bond analysis. Peptide
coverage for all LC-MS/MS experiments was greater than 80%.
Electrophoretic mobility shift assay (EMSA)
EMSAs were performed as described (10) with the following modifications. 0.3 mM
purified APE1 proteins ( full-length APE1, Δ40APE1 and NEM modified full-length APE1
and Δ40APE1) were reduced with 1.0 mM DTT for 10 min and diluted to yield a final
concentration of 0.06 mM with 0.2 mM DTT in PBS. 2 μL of each reduced APE1 protein
(0.006 mM) was added to EMSA reaction buffer (10 mM Tris [pH 7.5], 50 mM NaCl, 1 mM
MgCl2, 1 mM EDTA, 5% [vol/vol] glycerol) with 2 μL of 0.007 mM protein mixture (1:1)
of purified truncated c-Jun and c-Fos proteins containing the DNA-binding domain and the
leucine zipper region (oxidized with 0.01 mM diamide for 10 minutes) in total volume 18
μL. Samples were incubated for 30 min at room temperature, and then the EMSA assay was
performed as previously described (10).
Results
Interaction of E3330 with Δ40APE1
As a first step toward elucidating the mechanism by which APE1 reduces transcription
factors, we considered that a study of the interaction of E3330, which inhibits the redox
activity of APE1, may provide insight. We elected to perform our initial studies using
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Δ40APE1, a construct lacking the N-terminal 40 amino acids, which is easily purified from
E. coli to greater than 95% homogeneity, behaves well in ESI mass spectrometry
experiments, is fully functional as an endonuclease in vitro (28), and retains near wild-type
redox activity (10). To examine the nature of the interaction, we subjected Δ40APE1
incubated with E3330 to both native (29-31) and denaturing ESI-MS analysis. As shown in
Figures 1A and B, a weak interaction was observed in the native nESI-MS experiment.
Furthermore, the peaks representing the charge-state distribution of the protein and of the
protein/E3330 complexes were shifted to higher m/z. This shift could be caused by a small
change in protein conformation induced by a weak interaction with E3330, making
protonation more difficult and leading to lower charging.
Under denaturing ESI conditions, E3330 was observed to form adducts only under certain
conditions. As shown in Figure 1C, small peaks were seen consistent with the association of
E3330 with Δ40APE1 (Figure 1C) as indicated by a mass shift of 278 Da. In this case, it is
not possible to determine directly the nature of the complex as both covalent and non-
covalent adducts are expected to have the same mass difference. To determine whether
E3330 forms covalent adducts with Δ40APE1, an LC-MS/MS analysis was performed. No
E3330-modified peptides could be detected in this analysis indicating that the ESI-MS
experiments under both native and denaturing conditions are consistent with the formation
of a reversible adduct of E3330 and Δ40APE1.
Chemical footprinting analysis of the effects of E3330 on Δ40APE1
To elucidate further the nature of the interaction of E3330 with Δ40APE1, we developed a
MS-based chemical footprinting assay using N-methyl maleimide (NEM) to irreversibly
modify Cys residues in the protein. NEM specifically reacts with accessible cysteines via a
Michael addition and is widely used in protein footprinting (21,32-36). An important
advantage of NEM-labeling is the ability to probe solvent-accessible Cys residues along
with those that are exposed due to protein dynamics as demonstrated by Kaltahov and
coworkers in their study of interferon β-1a (37). Both global ESI-MS and LC-MS/MS
analyses were performed on Δ40APE1 samples. To establish the expected number of
modifications by NEM, fully denatured full-length APE1 and Δ40APE1 samples were
treated with NEM and subjected to ESI-MS analysis as described in the Supporting
Information. A maximum of 7 modifications were observed (Figure S1), consistent with the
7 Cys residues present in APE1.
In the absence of E3330, NEM specifically modifies Δ40APE1 to give a +2NEM modified
species as indicated by a shift in mass of 250 Da (Figure 2A). This product forms within 30
s of the addition of NEM and results in nearly 100% modification of Δ40APE1 within 10
min at room temperature as indicated by the time course of the reaction in Figure 3A,
notably by the disappearance of the peaks corresponding to unmodified Δ40APE1 in the
mass spectrum. Of the seven Cys residues within APE1, only Cys 99 and Cys 138, the two
solvent-accessible Cys residues (Figure 2A) were modified by NEM as determined by LC-
MS/MS of tryptic peptides produced from this NEM-labeled product.
The data in Figure 3A can be fit with a kinetic model (see Experimental Procedures) that
uses as free variables the rate constants for the reaction with NEM and the ionization
efficiencies of the various NEM adducts. The best fit (shown in Figure 3A) afforded a rate
constant for the reaction of NEM with a solvent-accessible Cys of 1020 min−1M−1. This
value is important for considerations of the subsequent reactions of the proteins with NEM
in the presence of E3330; it can be viewed as a measure of the intrinsic reactivity of a
solvent-accessible Cys with NEM.
Su et al. Page 6
Biochemistry. Author manuscript; available in PMC 2012 June 8.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
When Δ40APE1 was incubated with NEM and E3330, another major product corresponding
to the addition of 7 NEMs was observed. The +2NEM product forms rapidly, whether
E3330 is present or absent, whereas the +7NEM product arises slowly at room temperature
(Figure 3B) only when E3330 is present. The only other product observed was a small
amount of +3NEM product in reactions of Δ40APE1 with NEM or NEM and E3330 (Figure
2); LC-MS/MS analysis indicates that this product comes from the NEM reaction with other,
non-Cys, solvent-accessible sites (e.g., Lys, His, and the – NH2 at the terminus). Although
the general pKa values of Lys, His, and the terminal NH2 are higher than that of Cys, the
immediate environment around these residues may allow for a small extent of the Michael
addition. As for the reaction of Δ40APE1 and NEM, we also observed a small amount of the
+3NEM product in the reaction in which E3330 was included.
To determine whether the + 7NEM adduct was the result of E3330 denaturing the protein,
we incubated Δ40APE1 with E3330 for 24 h at room temperature and then added NEM.
After the NEM reaction was allowed to occur for 0.5 h, we observed only the +2NEM
product but not the +7NEM product. If E3330 were denaturing Δ40APE1, we would have
expected to modify all seven Cys residues with NEM.
Modeling the kinetics of the reaction of NEM with Δ40APE1 in the presence of E3330
brings insight on the mechanism of Ape1’s interaction with E3330. We focus on the slow
disappearance of the +2NEM species while the +7NEM product increased (Figure 3B).
Although there are seven Cys residues in the protein, we chose to use an initial ratio of 5:1
for [NEM]:[ Δ40APE1] to limit non-specific reactions of NEM with APE1 at other
nucleophilic sites than Cys. Once one or more of the five Cys residues remaining in the
+2NEM-modified Δ40APE1 become exposed, the protein is converted rapidly to a +7NEM
product until the [NEM] approaches zero. LC-MS/MS analysis confirmed that all seven Cys
residues in the +7NEM species are modified. The +7NEM products become detectable in
approximately 3 h, accumulating over a period of 24 h until the reagent NEM is depleted.
Over the same time period and temperature, no +7NEM modified species is formed in the
reaction of Δ40APE1 with NEM in the absence of E3330.
The +3NEM species does not change significantly during the time course of the reaction,
suggesting that it is not an intermediate in the formation of the +7NEM product (Figure 3B).
Furthermore, the appearance and abundance of this product are not affected by the presence
of E3330. This +3NEM species can ultimately give +8NEM via reactions that are parallel to
the reactions of +2NEM to give +7NEM.
The kinetics of the reaction of Δ40APE1 with NEM in the presence of E3330 (Figure 3B)
are consistent with the mechanism shown in Scheme 1. We infer from this and other
experiments described below that APE1 can adopt two different conformations, a native
fully folded state (F) and a locally or partially unfolded state (LU) as shown in equation (1).
Following the initial and rapid reactions of Δ40APE1 with two NEMs, equation (2) in
Scheme 1, is a much slower reaction leading ultimately to modification the five remaining
Cys residues of Δ40APE1. This reaction is not pseudo first order but second order as both
the [Δ40APE1] and [NEM] are changing. The kinetic fit can be explained by the model
shown in (3) of Scheme 1.
In this model, the rate-determining step is the interaction of E3330 with Δ40APE1 resulting
in the formation of a complex of E3330 with locally unfolded (LU) Δ40APE1. Although
this reaction is potentially an equilibrium reaction, equilibrium cannot become established
because LU is rapidly depleted by the reactions with NEM before it can revert. Reaction of a
formerly buried Cys residue with NEM serves to trap APE1 in this partially unfolded state.
The interaction with E3330 can be viewed a “wedging reaction” (i.e., one that holds open
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the unfolded protein until a newly exposed Cys is “trapped” by a relatively rapid reaction
with NEM. The best fit to the kinetic data give a kon of 1.1 min−1M−1, koff = 0.006 min−1.
The rate constant (kNEM) for reaction of newly exposed Cys residues is 1020 min−1M−1,
which is that for reaction of a solvent-accessible Cys. This rate constant was multiplied by 5
for the reaction of the 3rd NEM because five Cys residues are available. This factor of 5 has
little effect on the fit, however, because the reaction rate constant of solvent-accessible Cys
is nearly 1000 times that of the interaction with E3330.
A second model consistent with the kinetic data is one in which E3330 interacts weakly with
folded Δ40APE1 and is then converted to a locally unfolded Δ40APE1-E3330 complex
with the remainder of the proposed reaction scheme being the same. Although fitting of the
kinetic data cannot distinguish this model from that shown in Scheme 1, the kinetic fit, taken
together with the data from all of our experiments, indicates that the most probable
interaction of E3330 is with locally unfolded Δ40APE1. Both kinetic models require that
the rate of reaction increase with increases in the concentration of E3330, which was
observed (data not shown).
Temperature dependence of the E3330 induced NEM-modification of Δ40APE1
If formation of the +7NEM modified Δ40APE1 at room temperature occurred over a time
period of several hours, consistent with partial unfolding of the protein, we would expect the
reaction to occur more rapidly at higher temperature. Furthermore, if E3330 stabilizes one or
more locally unfolded states of the protein, allowing labeling of all seven Cys residues, we
might expect to populate this conformation at higher temperatures even in the absence of
E3330. Indeed, Δ40APE1, when treated with NEM at 37 °C, formed the expected +2NEM
product along with a small percentage of +7NEM product confirming that the protein does
adopt this conformation even in the absence of E3330 (Figure 4). In addition, the
modification of Δ40APE1 by NEM in the presence of E3330 should occur more rapidly at a
higher temperature. At 37 °C, the major product is the +7NEM modified species for a
reaction time of 30 min (Figure 4). These results also support partial unfolding of Δ40APE1
to expose the one or more buried Cys residues, which then react with NEM. This is more
evidence that folded Δ40APE1 exists in an equilibrium with locally unfolded Δ40APE1 as
shown in (1) of Scheme 1 with a distribution favoring the folded protein in the absence of
perturbation.
Role of Cys residues in the reaction of NEM/E3330 with Δ40APE1
Cys 65 is known to play a critical role in the redox activity of Δ40APE1. Thus, it was of
interest to determine whether Δ40APE1 must have Cys at site 65 to adopt a conformation
that reacts with NEM, leading ultimately to fully modified APE1. When C65A APE1 was
reacted with NEM in the presence of E3330, a +6 NEM species was observed, consistent
with labeling of all Cys residues in the protein (Figure S2). This result indicates that labeling
of the buried Cys residues in Δ40APE1 does not depend on the presence of Cys 65.
Another concern was whether the initial modification of Δ40APE1 forming the +2NEM
species labeled at Cys 99 and Cys 138 in some way facilitated or was required for NEM
reaction with the remaining Cys residues. Therefore, we reacted the C99A/C138A
substituted protein with NEM in the presence of E3330. The outcome of this reaction was
slow formation of a +5NEM labeled species in the same time frame as observed for the
unsubstituted protein (Figure S2). For this +5NEM labeled species, all buried Cys residues
of Δ40APE1 were modified with NEM, as determined by LC-MS/MS analysis of a tryptic
digest. Therefore, initial modification of Cys 99 and Cys 138 is not required for the
subsequent labeling of the buried Cys residues.
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Characterization of the NEM-modified Δ40APE1 species by HDX
To assess the conformational state of the +2NEM and the +7NEM Δ40APE1 species, we
measured the exchange of hydrogen for deuterium atoms within the peptide amides as a
function of time. Amides involved in hydrogen-bonding interactions within the protein
should exchange only slowly under the conditions used in this experiment. For the +2NEM
modified Δ40APE1, the kinetics of deuterium uptake were identical to that of the
unmodified Δ40APE1 protein; 144 hydrogen atoms underwent exchange to deuterium
(Figure 5 and Figure S3). For the +7NEM modified Δ40APE1, the deuterium uptake was
significantly higher; a total of 188 deuterium atoms exchanged (Figure 5). Using a kinetic
model (17), we fit the data by “binning” the number of amides that exchanged in 4 h into
fast, intermediate, and slow. We limited the model to that time because the exchange had
become “very slow” after 4 h, as indicated by the nearly flat kinetic curves at that time. For
the +2NEM adduct, the number of fast, intermediate, and slow exchanging amide H’s are
81± 1, 20 ± 4, 43 ± 2, respectively; for the + 3NEM adduct, the number of amides are 81 ±
2, 19 ± 2, 41 ± 1, whereas for the + 7NEM adduct, the numbers are 136 ± 3, 14 ± 1, 38 ± 4.
Clearly, the number of fast exchanging amide H’s has increased substantially for the
+7NEM adduct, consistent with it being a partially unfolded conformer that becomes
“locked-in” or “trapped” as a result of the reaction with NEM. The +7NEM adduct has ~40
more exchanging amide H’s than Δ40APE1, +2NEM adduct, or the + 3NEM adduct. The
protein contains a total of 278 amide hydrogen atoms, of which 51% are exchanged in the
wild-type protein and 67% in the +7NEM adduct. Therefore, the +7NEM modified
Δ40APE1 represents a partially but not completely unfolded state of the enzyme; it is
clearly distinct from wild-type or the +2NEM modified protein.
The effect of NEM modification on APE1’s redox activity
Given that it is the +2NEM-modified Δ40APE1 that is converted to a +7NEM product, we
sought to determine whether the +2 NEM species retains redox activity and, therefore,
represents a biologically active form of the enzyme. Accordingly, NEM-treated Δ40APE1
and full-length APE1 were subjected to global ESI-MS analysis to confirm that the reactions
produced a +2NEM modified species for each sample. The products were then analyzed for
redox activity using an EMSA redox assay. In this assay, the redox activities of +2NEM-
modified APE1 samples were compared to those of a redox-inactive control, C65A APE1
and of Δ40APE1 or full-length APE1. As shown in Figure 6, the +2NEM-labeled samples
retained ~90% of full-length or Δ40APE1 activity. Therefore, the +2NEM modification of
APE1 does not significantly reduce its redox activity. This result is consistent with results
obtained for single Cys mutants of APE1 in which C99A and C138A APE1 samples retain
near wild-type redox activity (9,10). Modification of all 7 Cys residues in APE1 by NEM
when E3330 is present would be expected to cause loss of redox activity.
Effect of E3330 on disulfide bond formation in Δ40APE1
The redox activity of APE1 requires Cys 65 and, therefore, is thought to involve a thiol-
mediated disulfide exchange reaction. If Cys 65 serves as the nucleophilic thiol in the
reduction of transcription factors by APE1, it must exist in a reduced state. Further, other
participating Cys residues must be available to reduce the mixed disulfide formed between
Cys 65 and a Cys residue within the transcription factor. Therefore, we asked whether
E3330 affects the formation of disulfide bonds in Δ40APE1, particularly those that play an
important role in the redox activity. When Δ40APE 1 was treated with E3330, the relative
abundance of disulfide bonds in Δ40APE1 of C65-C93, C93-C99, C93-C138, and C65-C99
increased from 0.16, 0.04, 0.01, and 0.01 to 8.2, 5.8, 2.6, and 2.6%, respectively, as
determined by LC-MS/MS analysis of tryptic fragments (results in Figure 7). Percentage
values reflect the abundance of disulfide-bonded peptides as normalized to an internal
peptide that was used for quantitation (38,39) as described in the Experimental Procedures.
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Product-ion (MS2) spectra identifying the disulfide linkages (Figure S4) show that the
relative abundance of each of the disulfide-bonded peptides increased significantly
following treatment with E3330. Both Cys 65 and Cys 93 play an important role in the redox
activity of APE1(9,10), and all of the observed disulfide bonds involve either Cys 65 or Cys
93. Therefore, all of these disulfide bonds would be expected to impact the redox activity of
APE1.
Comparison of full-length APE1 with Δ40APE1
An important question is whether the N-terminal residues in the full-length APE1 affect the
ability of the protein to unfold partially, providing access of NEM to buried Cys residues as
is true for the Δ40APE1 protein. Following incubation of full-length APE1 with NEM/
E3330 under conditions similar to those used for the Δ40APE1 experiments, we observed
the same major products by ESI-MS, +2NEM and +7NEM adducts (Figure 8). Thus, the
full-length APE1 behaves similarly to Δ40APE1, and the conclusions from MS study of
Δ40APE1 are applicable to the full-length APE1, which also undergoes the partial unfolding
event(s) allowing NEM to react with buried Cys residues within APE1.
Discussion
Taken together, our data provide the first definitive evidence that APE1 can adopt a partially
or locally unfolded conformation. Three lines of evidence confirm the partially unfolded
conformation. First, the chemical footprinting experiments with NEM in the presence of
E3330 show that all seven Cys residues react with NEM although only two of the seven Cys
residues are solvent-accessible in the native state of the protein. Therefore, an unfolding
event must occur to allow the remaining Cys residues to be modified by NEM. Second, the
kinetics modeling is consistent with a rate-determining reaction of E3330 with a small
population of locally unfolded protein that possesses one or more newly exposed Cys
residues. The reaction is necessarily slow because the reactive concentration is small. The
reaction stabilizes the partially unfolded protein, allowing that small fraction to react rapidly
with NEM. Subsequent additional unfolding exposes more Cys residues for reaction with
NEM until all seven are rapidly modified. Third, the HDX kinetics, as determined by mass
spectrometry, demonstrate an additional uptake of approximately 40 deuterium atoms in the
+7NEM adduct as compared to the +2NEM or wild-type protein.
An important feature of the locally unfolded conformation of APE1 is that Cys 65, the
residue critical for the redox activity of APE1, becomes exposed as demonstrated by
reactivity with NEM in the presence of E3330. However, E3330 is not necessary for APE1
to sample this locally unfolded state. This is demonstrated by reaction, in the absence of
E3330, of buried Cys residues with NEM, at the physiologically relevant temperature of 37
°C. As expected, at an elevated temperature, the equilibrium between the folded and locally
unfolded states of APE1 is shifted in favor of the unfolded species, allowing a small amount
of the +7NEM product to be produced more rapidly (i.e. within 30 min). In the presence of
E3330 at 37 °C, approximately 80% of the sample is fully modified by NEM within 30 min.
As demonstrated in the chemical footprinting experiments, perturbation of the equilibrium
between folded and locally unfolded states of APE1 occurs through interaction with E3330,
a redox inhibitor of APE1. In its capacity as a redox factor, we suggest that interaction with
oxidized transcription factors similarly perturbs this equilibrium governing the
conformational states of APE1.
Our studies also provide a basis for understanding the mechanism by which E3330 inhibits
the redox activity of APE1. Although our experiments do not support strong binding of
E3330 as indicated by the previously reported Kd of 1.6 nM for E3330 binding to APE1(14),
they do confirm a novel mode of interaction for E3330 with APE1. Based on our chemical
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footprinting and HDX experiments, we propose that E3330 interacts with the locally
unfolded state of APE1, stabilizing it so that the normally buried Cys residues can react with
NEM. In shifting the equilibrium toward the locally unfolded state of APE1, E3330 also
facilitates disulfide bond formation in APE1. The mechanism by which E3330 increases
disulfide bond formation may involve reversible activation of a Cys residue by E3330,
making that Cys residue susceptible to nucleophilic attack by a reduced Cys residue. Of
particular relevance is the fact that all of the disulfide bonds identified involve the critical
redox residues Cys 65 and/or Cys 93 (9,10) and that both of these Cys residues are buried in
the folded conformation of APE1. This indicates that disulfide bond formation occurs in the
locally unfolded form of the protein. Our current model is that E3330 acts by increasing
disulfide bond formation involving Cys 65 and/or Cys 93, effectively decreasing the redox
active population of APE1 molecules.
The results from interaction of APE1 with E3330 have implications on the general redox
properties of this protein. It may be that the redox active form of APE1 is the locally
unfolded unfolded form of the enzyme; the unfolding exposes the critical Cys 65 residue,
thereby making it available for a thiol-mediated/disulfide exchange reaction with a
transcription factor.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
NanoESI mass spectra of Δ40APE1 without (A) and with E3330 (B). Samples were
incubated in 1 M ammonium acetate at pH 7.5 for 4 h at RT and then directly analyzed by
nESI-MS ([protein] = 100 μm; [E3330] = 500 μm). Mass spectra were collected on a Bruker
MaXis UHR-TOF instrument. (C) ESImass spectrum of Δ40APE1 and E3330 with 50%
ACN with 0.1% FA at 10 μL/min. Sample was incubated in 100 mM ammonium
bicarbonate at pH 7.5 for 4 h at RT and before MS analysis: [protein] = 100 μm; [E3330] =
500 μm. The symbol * denotes peaks for the water and salt adducts. Data were collected on
a Waters Micromass Q-TOF instrument, and deconvolution was done with MaxEnt1
algorithm provided with that system. Instrument parameters were the same as described in
the HDX experiments except theflow rate was 10 μL/min, capillary voltage was 2.5 kV, and
the collision energy was 5 eV.
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Figure 2.
ESI mass spectra of Δ40APE1 after incubation without (A) and with E3330 (B) in the
presence of NEM for 30 min (left panel) and 6 h (right panel). Samples were incubated in 10
mM HEPES with 150 mM KCl at pH 7.5([protein] = 100 μm; [E3330] = [NEM] = 500 μm).
The symbol * denotes peaks for the water adducts. Mass spectra were collected on a Waters
Micromass Q-TOF instrument and deconvolution was done with MaxEnt1 algorithm
provided with that system.
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Figure 3.
Kinetics of Δ40APE1 reaction with NEM (A) or NEM and E3330 (B). Both samples were
prepared in 10 mM HEPES at pH 7.5 at RT ([protein] = 100 μm; [E3330] = [NEM] = 500
μm). Aliquots were quenched with DTT at various times. Mass spectra were collected on a
Bruker MaXis UHR-TOF instrument, and deconvolution was done with MaxEnt1 algorithm
provided with that system. The sums of intensities of different NEM adducts of Δ40APE1
were normalized to 1. Data were fitted with Mathcad using a relatively straight forward one-
parameter fit of the + 2 NEM adduct kinetic curves and a three parameter fit varying
kslowNEM, kON, and gN was used to fit the + 7 NEM adduct kinetic curves.
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Figure 4.
ESI mass spectra of ApeΔ40 without and with incubation with E3330 in the presence of
NEM for 0.5 h at 37 °C. Sample was incubated in 10 mM HEPES at pH 7.5([protein] = 10
μm; [E3330] = [NEM] = 50 μm). Mass spectrum was collected on a Bruker MaXis UHR-
TOF instrument and deconvolution was done with MaxEnt1 algorithm.
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Figure 5.
HDX kinetics results of “Δ40APE1 + 2 NEM”, “Δ40APE1 + 3 NEM” and “Δ40APE1 + 7
NEM”. Δ40APE1/E3330/NEM sample was incubated in 10 mM HEPES with 150mM KCl
(pH 7.5) for 22 h at RT ([protein] = 100 μm; [E3330] = [NEM] = 500 μm). Reaction was
quenched by adding DTT. HDX was conducted in a 93% D2O medium with 10 mM HEPES
(pH 7.5) and 150 mM KCl at 25 °C and quenched by adding sufficient 1 M cold HCl to give
a pH of 2.5. The curves were plotted with data from 3 independent experimental replicates.
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Figure 6.
EMSA redox assay comparing the redox activity of +2 NEM modified full-length APE1 and
Δ40APE1 to the unmodified enzymes. The redox inactive C65A enzyme is included as a
control. APE1 samples either untreated (left lanes labeled “unreduced proteins”) or
pretreated (right lanes labeled “reduced proteins with 0.02 mM DTT”) were used in the
assay. APE1 proteins were reduced with 1 mM DTT as described in the Experimental
Procedures and diluted yielding final concentrations in the assay of 0.006 mM APE1 and
0.02 mM DTT. Oxidized c-Jun/c-Fos (0.007 mM) was incubated for 30 min with reduced
APE1 in EMSA reaction buffer. The EMSA assay was performed as described in the
Experimental Procedures. (A) Gel and (B) quantitation of the gel. At least three independent
experiments were done, and the results of a representative experiment are shown here.
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Figure 7.
Normalized percentages of disulfide linkages in the Δ40APE1 control and Δ40APE1/E3330
samples. Samples were prepared by incubating the protein without (control) and with E3330
in 10 mM HEPES at pH 7.5 for 1 h at 37 °C ([protein] = 10 μm; [E3330] = 50 μm). An
excess of NEM (protein/NEM = 1/50, mol/mol) was immediately added to quench the
disulfide crosslinking reaction and prevent disulfide scrambling during the subsequent
digestion process. Data base searching was done with MassMatrix, an algorithm with the
ability to identify disulfide-linked and crosslinked peptides (25-27). The amounts of
peptides were estimated by dividing the peak areas in the LC chromatogram of the disulfide-
linked peptides by that of a “standard” peptide “WDEAFR” in the sequence, which does not
become modified during the sample preparation and LC-MS/MS analysis process. The
assumption for this method is that there is no or little ionization discrimination between the
“standard” peptide and the didulfide linked peptides. No C65-C138 linkage was observed in
the control sample. Bars represent “mean ± standard derivation” taken from triplicate
measurements.
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Figure 8.
ESI mass spectrum of full-length APE1 (FL-APE1) with E3330 in the presence of NEM for
12 h. Sample was incubated in 10 mM HEPES at pH 7.5([protein] = 100 μm; [E3330] =
[NEM] = 500 μm). Mass spectrum was collected on a Bruker MaXis UHR-TOF instrument
and deconvolution was done with MaxEnt1 algorithm.
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Scheme 1.
Equations are shown for an equilibrium of folded (F) and locally unfolded (LU)
conformations of Δ40APE1 in (1), Δ40APE1’s initial fast reaction of solvent accessible Cys
residues with NEM to give a +2NEM species (2), and the reaction of Δ40APE1 with NEM
in the presence of E3330 leading to a +7NEM modified Δ40APE1.
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